C. Baston

480 total citations
35 papers, 277 citations indexed

About

C. Baston is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Transplantation. According to data from OpenAlex, C. Baston has authored 35 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 6 papers in Transplantation. Recurrent topics in C. Baston's work include Renal Transplantation Outcomes and Treatments (6 papers), Prostate Cancer Treatment and Research (5 papers) and Renal cell carcinoma treatment (4 papers). C. Baston is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Prostate Cancer Treatment and Research (5 papers) and Renal cell carcinoma treatment (4 papers). C. Baston collaborates with scholars based in Romania, Germany and United States. C. Baston's co-authors include I. Sinescu, Gener Ismail, Bogdan Obrișcă, Bogdan Sorohan, Andreea Andronesi, Ileana Constantinescu, Adrian Preda, Nicolae Leca, Daniela Luiza Baconi and Anca Silvia Dumitriu and has published in prestigious journals such as Scientific Reports, Medicine and BioMed Research International.

In The Last Decade

C. Baston

31 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Baston Romania 12 76 72 61 51 37 35 277
Aris Tsalouchos Italy 9 82 1.1× 40 0.6× 86 1.4× 42 0.8× 43 1.2× 35 249
Owen Kwon South Korea 10 81 1.1× 24 0.3× 65 1.1× 72 1.4× 38 1.0× 12 314
Abdul Abdellatif United States 13 82 1.1× 52 0.7× 42 0.7× 133 2.6× 19 0.5× 31 356
Isabel Roberti United States 10 116 1.5× 61 0.8× 153 2.5× 98 1.9× 56 1.5× 22 306
Y. Tanter France 11 61 0.8× 87 1.2× 39 0.6× 79 1.5× 24 0.6× 31 283
G.F. Zanon Italy 8 83 1.1× 53 0.7× 58 1.0× 22 0.4× 58 1.6× 25 281
M.İ. Titiz Türkiye 10 77 1.0× 56 0.8× 53 0.9× 26 0.5× 20 0.5× 26 315
Yudo Tanno Japan 12 117 1.5× 68 0.9× 91 1.5× 232 4.5× 32 0.9× 65 399
Agnieszka Prytula-Ebels Belgium 10 75 1.0× 37 0.5× 120 2.0× 167 3.3× 47 1.3× 33 361
Elisabeth Dittrich Austria 9 109 1.4× 44 0.6× 157 2.6× 130 2.5× 35 0.9× 12 385

Countries citing papers authored by C. Baston

Since Specialization
Citations

This map shows the geographic impact of C. Baston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Baston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Baston more than expected).

Fields of papers citing papers by C. Baston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Baston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Baston. The network helps show where C. Baston may publish in the future.

Co-authorship network of co-authors of C. Baston

This figure shows the co-authorship network connecting the top 25 collaborators of C. Baston. A scholar is included among the top collaborators of C. Baston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Baston. C. Baston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baston, C., et al.. (2025). Early-Stage Renal Cell Carcinoma: Who Needs Adjuvant Therapy?. Biomedicines. 13(3). 543–543.
2.
Baston, C., et al.. (2024). Tumor-to-Tumor Metastasis of Lung Cancer to Kidney Cancer: A Review of the Literature and Our Experience. Diagnostics. 14(5). 553–553. 5 indexed citations
3.
Surcel, C., Robert Dotzauer, Călin Popa, et al.. (2024). Current role of intraoperative cell salvage techniques in the management of renal tumors with level III and IV inferior vena cava thrombus extension. Therapeutic Advances in Urology. 16. 3643575744–3643575744. 1 indexed citations
4.
Baston, C., et al.. (2023). Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive Biomarkers. Diagnostics. 13(14). 2430–2430. 3 indexed citations
5.
Anton, Gabriela, et al.. (2022). Cumulative Effect Assessment of Common Genetic Variants on Prostate Cancer: Preliminary Studies. Biomedicines. 10(11). 2733–2733.
6.
Sorohan, Bogdan, et al.. (2022). Mycobacterium Tuberculosis Infection after Kidney Transplantation: A Comprehensive Review. Pathogens. 11(9). 1041–1041. 4 indexed citations
7.
Ismail, Gener, et al.. (2022). Genetic variant located on chromosome 17p12 contributes to prostate cancer onset and biochemical recurrence. Scientific Reports. 12(1). 4546–4546. 2 indexed citations
8.
Surcel, C., Isabel Heidegger, Apostolos P. Labanaris, et al.. (2022). Challenges in Diagnosis of Uretero–Arterial Fistulas after Complex Pelvic Oncological Procedures—Single Center Experience and Review of the Literature. Diagnostics. 12(8). 1832–1832.
9.
Sorohan, Bogdan, Andreea Andronesi, Gener Ismail, et al.. (2020). Clinical Predictors of Preeclampsia in Pregnant Women with Chronic Kidney Disease. Medicina. 56(5). 213–213. 3 indexed citations
10.
Sorohan, Bogdan, Gener Ismail, Nicolae Leca, et al.. (2020). Angiotensin II type 1 receptor antibodies in kidney transplantation: An evidence-based comprehensive review. Transplantation Reviews. 34(4). 100573–100573. 28 indexed citations
11.
Heidenreich, Axel, et al.. (2020). Treatment of the primary in metastatic prostate cancer. Current Opinion in Urology. 30(4). 566–575. 3 indexed citations
12.
Sorohan, Bogdan, Gener Ismail, Andreea Andronesi, et al.. (2019). A single-arm pilot study of metformin in patients with autosomal dominant polycystic kidney disease. BMC Nephrology. 20(1). 276–276. 12 indexed citations
13.
Obrișcă, Bogdan, Bogdan Sorohan, Laura Iliescu, et al.. (2019). Clinical outcome of HCV-associated cryoglobulinemic glomerulonephritis following treatment with direct acting antiviral agents: a case-based review. Clinical Rheumatology. 38(12). 3677–3687. 11 indexed citations
14.
Preda, Adrian, et al.. (2019). Influences of angiotensin I-converting enzyme gene insertion/deletion polymorphism on prostate cancer risk in Romania. ROMANIAN BIOTECHNOLOGICAL LETTERS. 24(6). 1043–1049. 3 indexed citations
15.
Iordache, Alexandru, et al.. (2018). Ultrasound for kidney access in percutaneous nephrolithotomy: a contemporary review. Medical Ultrasonography. 20(4). 508–508. 7 indexed citations
16.
Motofei, Ion G., David L. Rowland, Daniela Luiza Baconi, et al.. (2017). Therapeutic Considerations Related to Finasteride Administration in Male Androgenic Alopecia and Benign Prostatic Hyperplasia. FARMACIA. 65(5). 22 indexed citations
18.
Hârza, Mihai, et al.. (2014). Predictive Factors for Natural Pregnancy after Microsurgical Reconstruction in Patients with Primary Epididymal Obstructive Azoospermia. International Journal of Endocrinology. 2014. 1–6. 6 indexed citations
19.
Baston, C., et al.. (2014). Impact of Ureteral Stenting on Urological Complications After Kidney Transplantation Surgery: A Single-Center Experience. Transplantation Proceedings. 46(10). 3459–3462. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026